Tanabe Research Laboratories USA Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tanabe Research Laboratories USA Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10796
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tanabe Research Laboratories USA Inc (Tanabe Research Laboratories USA), a subsidiary of Mitsubishi Tanabe Pharma Corp is a healthcare research center that discovers and develops biological drugs. The laboratory conducts research on metabolics, immunology and inflammation. Its products are used for the therapy of serious diseases with unmet needs. Tanabe Research Laboratories USA conducts antibody related research to target specific immune cells and soluble factors. The laboratory investigates new methods for modulating immune cell functions. It also works with academic research organizations and pharma, medical and healthcare companies. Tanabe Research Laboratories USA is headquartered in San Diego, California, the US.

Tanabe Research Laboratories USA Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
AvantGen Partners with Tanabe Research Laboratories USA 10
Licensing Agreements 11
Tanabe Research Labs Enters into a Licensing Agreement with MedImmune 11
Covagen Enters Into Licensing Agreement With Mitsubishi Tanabe Pharma And Tanabe Research Labs 12
Covagen Expands Licensing Agreement With Mitsubishi Tanabe Pharma And Tanabe Research Labs 14
Tanabe Research Laboratories USA Inc – Key Competitors 16
Tanabe Research Laboratories USA Inc – Key Employees 17
Tanabe Research Laboratories USA Inc – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Key Facts 2
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tanabe Research Laboratories USA Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AvantGen Partners with Tanabe Research Laboratories USA 10
Tanabe Research Labs Enters into a Licensing Agreement with MedImmune 11
Covagen Enters Into Licensing Agreement With Mitsubishi Tanabe Pharma And Tanabe Research Labs 12
Covagen Expands Licensing Agreement With Mitsubishi Tanabe Pharma And Tanabe Research Labs 14
Tanabe Research Laboratories USA Inc, Key Competitors 16
Tanabe Research Laboratories USA Inc, Key Employees 17

List of Figures
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Tanabe Research Laboratories USA Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Micromem Technologies Inc (MRM):企業の財務・戦略的SWOT分析
    Summary Micromem Technologies Inc (Micromem) is a technology company that develops and markets magnetic sensor products. The company designs and develops sensors specific to industrial requirements. It offers solutions such as nanoparticle detection solutions, structural integrity sensors, oil well …
  • Bird Rock Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary Bird Rock Bio Inc (Bird Rock Bio), formerly RuiYi Inc is a clinical stage biopharmaceutical company that develops immuno-inflammatory regulators. The company’s products under development include RYI-018 is a peripheral antagonist antibody to cannabinoid receptor 1 intended for the treatment …
  • NRG Energy Inc (NRG):企業の財務・戦略的SWOT分析
    NRG Energy Inc (NRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Glenmark Pharmaceuticals Ltd (GLENMARK):製薬・医療:M&Aディール及び事業提携情報
    Summary Glenmark Pharmaceuticals Ltd (Glenmark) is a pharmaceutical company which focuses on the discovery of new chemical entities (NCEs) and new biological entities (NBEs). The company's formulations business encompasses therapeutic areas such as dermatology, anti-infective, respiratory, central n …
  • HC Slingsby Plc:企業の戦略・SWOT・財務情報
    HC Slingsby Plc - Strategy, SWOT and Corporate Finance Report Summary HC Slingsby Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • AccuVein Inc:医療機器:M&Aディール及び事業提携情報
    Summary AccuVein Inc (AccuVein) is a medical device company that provides medical imaging solutions. The company’s products include AV400 vein viewing system, HF470 extended reach powered wheeled stand, HF450 unpowered wheeled stand, and HF410 hands-free solution. Its AV400 vein viewing system digit …
  • Plastopil Hazorea Company Ltd:企業の戦略・SWOT・財務情報
    Plastopil Hazorea Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Plastopil Hazorea Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Getac Technology Corporation:企業の戦略・SWOT・財務情報
    Getac Technology Corporation - Strategy, SWOT and Corporate Finance Report Summary Getac Technology Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • China Environmental Energy Investment Limited:企業のM&A・事業提携・投資動向
    China Environmental Energy Investment Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Environmental Energy Investment Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, …
  • Advanced Accelerator Applications SA (AAAP):企業の財務・戦略的SWOT分析
    Summary Advanced Accelerator Applications SA (AAA), a Novartis company, is engaged in developing, producing and commercializing diagnostic and therapeutic molecular nuclear medicine products. The company’s lead product candidate comprises Lutathera, NETSPOT, SOMAKIT TOC, Gluscan, Gluscan 500, Barnas …
  • Aesculap Inc-医療機器分野:企業M&A・提携分析
    Summary Aesculap Inc (Aesculap) is a medical device company that offers medical implants, surgical implants, and other related devices. The company’s products comprise neurosurgery products, power systems, sterile processing products, surgical instruments, and wound closure products. It offers servi …
  • Ashok Leyland Limited:企業の戦略・SWOT・財務情報
    Ashok Leyland Limited - Strategy, SWOT and Corporate Finance Report Summary Ashok Leyland Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Marathon Petroleum Corp (MPC):石油・ガス:M&Aディール及び事業提携情報
    Summary Marathon Petroleum Corp (MPC) is a downstream energy company, which refines, markets and transports petroleum products. It owns and operates refineries in the Gulf Coast and Midwest regions of the US. MPC owns common carrier pipeline systems that transport crude oil and refined products to t …
  • National Bank of Egypt S.A.E:企業の戦略・SWOT・財務情報
    National Bank of Egypt S.A.E - Strategy, SWOT and Corporate Finance Report Summary National Bank of Egypt S.A.E - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • KSK Energy Ventures Ltd (KSK):企業の財務・戦略的SWOT分析
    KSK Energy Ventures Ltd (KSK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Subaru Corporation (7270):企業の財務・戦略的SWOT分析
    Subaru Corporation (7270) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Vulcan Materials Company
    Vulcan Materials Company - Strategy, SWOT and Corporate Finance Report Summary Vulcan Materials Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • LBT Innovations Limited (LBT)-医療機器分野:企業M&A・提携分析
    Summary LBT Innovations Limited (LBT) is a medical device company that designs, develops and commercializes various products and automation technologies for the preparation and analysis of microbiology culture specimens, and microbiology and diagnostic laboratory services. It offers MicroStreak tech …
  • PRA Health Sciences Inc (PRAH):企業の財務・戦略的SWOT分析
    Summary PRA Health Sciences Inc (PRA) is a contract research organization (CRO) which provides clinical development services. The company offers services which include phase I-IV study management, bioanalytical services, biometrics, clinical pharmacology, strategic solutions, post-marketing research …
  • Nexira:戦略・SWOT・企業財務分析
    Nexira - Strategy, SWOT and Corporate Finance Report Summary Nexira - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆